- ISIN
- US6960774031
- CUSIP
- 696077403
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 28, 1993
Highlights
- Market Cap
- $52.81M
- Enterprise Value
- $43.13M
- EPS (TTM)
- -$2.39
- Total Revenue (TTM)
- $8.96M
- Gross Profit (TTM)
- $8.90M
- EBITDA (TTM)
- -$6.39M
- Year Range
- $7.25 - $31.00
- Target Price
- $55.00
- ROA (TTM)
- -47.25%
- ROE (TTM)
- -59.00%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PTN Performance Chart
Palatin Technologies, Inc. (PTN) is down 12.2% since the beginning of the year. At $14 per share, PTN is trading 56.5% below its 52-week high of $31.
Loading charts...
Returns By Period
Palatin Technologies, Inc.
- 1D
- -2.88%
- 1M
- -32.63%
- YTD
- -12.22%
- 6M
- -21.05%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
PTN Monthly Returns History
Based on dividend-adjusted daily data since Nov 12, 2025, PTN's average daily return is +0.50%, while the average monthly return is +7.31%. At this rate, an investment would double in approximately 0.8 years.
Historically, 38% of months were positive and 63% were negative. The best month was Nov 2025 with a return of +77.0%, while the worst month was May 2026 at -30.6%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 2 months.
On a daily basis, PTN closed higher 46% of trading days. The best single day was Nov 21, 2025 with a return of +57.5%, while the worst single day was Dec 17, 2025 at -17.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.36% | 42.08% | -16.65% | 16.02% | -30.63% | -3.71% | -12.22% | ||||||
| 2025 | 76.99% | -21.29% | 39.31% |
Benchmark Metrics
Palatin Technologies, Inc. has an annualized alpha of 242.24%, beta of 0.16, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 13, 2025.
- This stock tended to rise when S&P 500 Index fell (downside capture of -1404.98%), but participation in market rallies was also limited (-70.63%) - a profile typical of counter-cyclical assets.
- Beta of 0.16 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 242.24%
- Beta
- 0.16
- R²
- 0.00
- Upside Capture
- -70.63%
- Downside Capture
- -1,404.98%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Palatin Technologies, Inc. (PTN) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Palatin Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Palatin Technologies, Inc. was 51.79%, occurring on Jun 3, 2026. The portfolio has not yet recovered.
The current Palatin Technologies, Inc. drawdown is 51.79%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -51.79%Jun 2026 | 5mo 19d | — | 5mo 20dDec 2025 - now |
2025 bear market2025 | -25.59%Nov 2025 | 2d | 9d | 11dNov 2025 - Dec 2025 |
2025 correction2025 | -10.29%Dec 2025 | 1d | 4d | 5dDec 2025 - Dec 2025 |
2025 pullback2025 | -7.04%Dec 2025 | 0s | 1d | 1dDec 2025 - Dec 2025 |
2025 pullback2025 | -2.17%Nov 2025 | 0s | 4d | 4dNov 2025 - Nov 2025 |
Drawdown Indicators
| PTN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.79% | -56.78% | +4.99% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -51.79% | -0.74% | -51.05% |
Average DrawdownAverage peak-to-trough decline | -29.58% | -10.72% | -18.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Palatin Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Palatin Technologies, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PTN relative to other companies in the Biotechnology industry. Currently, PTN has a P/S ratio of 3.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PTN in comparison with other companies in the Biotechnology industry. Currently, PTN has a P/B value of 5.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PTN
Add Palatin Technologies, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PTN